To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.

DoD biotechnology office and funding

This bill would require the Secretary of Defense to name a senior biotechnology official within 90 days of enactment. That official would head a new Biotechnology Management Office chartered within 120 days under the Deputy Secretary. The office would keep a long-term R&D, acquisition, and sustainment roadmap; update DoD biotech adoption and acquisition guidance; coordinate with federal, industry, academic, and international partners; propose streamlining options; conduct global analyses and forecasting; support public‑private partnerships and regional innovation ecosystems; and identify workforce and training gaps. The Secretary would brief congressional defense committees within 30 days after the official is named on the office charter and first-year implementation plans. The section creating the office would terminate on September 30, 2030. If enacted, the bill would also let DoD research, development, test, and evaluation (RDT&E) funds be used to carry out bioindustrial manufacturing research, including related design and construction, effective upon enactment.